We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+7.66%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$455B
AUM Growth
+$26.6B
Cap. Flow
-$26.7B
Cap. Flow %
-5.87%
Top 10 Hldgs %
33.25%
Holding
16,292
New
1,467
Increased
6,223
Reduced
6,687
Closed
1,652

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$645M
2
TMUS icon
T-Mobile US
TMUS
+$640M
3
T icon
AT&T
T
+$517M
4
HUM icon
Humana
HUM
+$481M
5
BSX icon
Boston Scientific
BSX
+$400M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.24B
2
AAPL icon
Apple
AAPL
+$755M
3
META icon
Meta Platforms (Facebook)
META
+$707M
4
CAT icon
Caterpillar
CAT
+$472M
5
AMD icon
Advanced Micro Devices
AMD
+$449M

Sector Composition

Rank Sector Weight
1 Healthcare 3.33%
2 Technology 3.2%
3 Financials 2.22%
4 Industrials 2.17%
5 Consumer Discretionary 2.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTEV
14301
PUT
Claritev Corp
CTEV
$646M
$954 ﹤0.01%
23
-1,412
-98% -$63.8K
VIRX
14302
CALL
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$954 ﹤0.01%
600
-21,140
-97% -$38.4K
NOGNW
14303
DELISTED
Nogin, Inc. Warrant
NOGNW
$935 ﹤0.01%
+33,047
New +$1.27K
TRKAW
14304
DELISTED
Troika Media Group, Inc. Warrant
TRKAW
$935 ﹤0.01%
+13,545
New +$1K
CEI
14305
DELISTED
Camber Energy, Inc
CEI
$932 ﹤0.01%
590
-11,032
-95% -$19.1K
TIL icon
14306
PUT
Instil Bio
TIL
$50.1M
$925 ﹤0.01%
70
+20
+40% +$296
JNCE
14307
PUT
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$925 ﹤0.01%
500
+400
+400% +$495
THRN
14308
CALL
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
$924 ﹤0.01%
+200
New +$880
CTKB icon
14309
PUT
Cytek Biosciences
CTKB
$610M
$919 ﹤0.01%
100
-200
-67% -$2.15K
DLPN icon
14310
PUT
Dolphin Entertainment
DLPN
$15.6M
$905 ﹤0.01%
250
-450
-64% -$1.88K
ALXO icon
14311
PUT
ALX Oncology
ALXO
$271M
$904 ﹤0.01%
200
-1,200
-86% -$9.09K
TIOAW
14312
DELISTED
Tio Tech A Warrants
TIOAW
$897 ﹤0.01%
183,073
-366,571
-67% -$6.56K
CLIR icon
14313
PUT
ClearSign Technologies
CLIR
$31.7M
$878 ﹤0.01%
110
+10
+10% +$76
KORU icon
14314
PUT
Direxion Daily MSCI South Korea Bull 3X ETF
KORU
$1.69B
$877 ﹤0.01%
+200
New +$904
HGTY icon
14315
PUT
Hagerty
HGTY
$1.32B
$874 ﹤0.01%
+100
New +$912
CYCN icon
14316
PUT
Cyclerion Therapeutics
CYCN
$17.7M
$868 ﹤0.01%
100
-20
-17% -$252
EVC icon
14317
Entravision Communication
EVC
$832M
$865 ﹤0.01%
143
-165,830
-100% -$1.03M
CCLP
14318
CALL
DELISTED
CSI Compressco LP
CCLP
$861 ﹤0.01%
700
-12,700
-95% -$17K
IGC icon
14319
PUT
IGC Pharma
IGC
$31.1M
$849 ﹤0.01%
2,500
-24,900
-91% -$9.34K
HTBK
14320
PUT
DELISTED
Heritage Commerce
HTBK
$833 ﹤0.01%
100
SEV
14321
CALL
DELISTED
Sono Group N.V. Common Shares
SEV
$812 ﹤0.01%
2,200
-5,600
-72% -$4.33K
QMCO icon
14322
CALL
Quantum Corp
QMCO
$1.03B
$805 ﹤0.01%
+35
New +$914
IFRX icon
14323
InflaRx
IFRX
$300M
$799 ﹤0.01%
412
-9,251
-96% -$20K
STKH
14324
CALL
Steakholder Foods
STKH
$2.13M
$792 ﹤0.01%
+1
New +$1.08K
LIDR icon
14325
PUT
AEye
LIDR
$60.9M
$787 ﹤0.01%
83
-207
-71% -$3.57K

Similar funds

Ken Griffin's Q1 2023 Portfolio in Review

As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.

Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.

  • Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
  • Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
  • Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
  • Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
  • Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
  • Ken Griffin opened 1,467 new positions and closed 1,652 in Q1 2023.
  • Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.